Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency. Indegene Ltd (NSE:INDGN) reports strong revenue growth and strategic acquisitions, while navigating margin challenges and segmental shifts. For authentication, use the same password as your Indegene email account. For inquiries about the MyIndegene homepage, reach out to [email protected] Indegene Career Acceleration Program This early leadership rotational program nurtures emerging business school talent through cross-functional exposure in strategy, operations, account management, and customer success along with a rigorous and formal training.
